Clover Health stock gains 6.85 percent to EUR 4.21 after hours

Published on 10/20/2026 at 20:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue reached USD 743.17 million. Clover Health stock costs EUR 4.21 on October 20, 2026, up 6.85 percent versus Tradegate's close.

Price move and reporting date

Clover Health stock gained 6.85 percent on October 20, 2026.
Second-quarter revenue reached USD 743.17 million versus USD 728.27 million expected on August 5, 2026.
Clover Health stock costs EUR 4.21 at Lang & Schwarz on October 20, 2026 at 8:47 p.m. CEST, 6.85 percent above the Tradegate close of October 19, 2026.
Clover Health reports third-quarter results on November 4, 2026 at 5:00 p.m. ET.

CLOV, US18914F1030, Illustration mit AI erstellt.

Clover Health Investments, Corp. (ISIN US18914F1030) stock gained 6.85 percent to EUR 4.21 on October 20, 2026, as the after-hours quote moved above the Tradegate close of October 19, 2026. The move puts the euro quotation near the upper end of its recent German trading range. Clover Health was trading at EUR 4.21 at Lang & Schwarz on October 20, 2026 at 8:47 p.m. CEST, up 6.85 percent versus the Tradegate close.

Revenue beat estimates in August

Clover Health's second-quarter revenue reached USD 743.17 million, compared with the USD 728.27 million consensus estimate. MarketBeat reported the figures on October 19, 2026, citing the results released on August 5, 2026. The revenue gap was USD 14.90 million, or 2.05 percent above expectations.

The same quarter produced earnings of USD 0.05 per share against a USD 0.04 consensus estimate. The result gives the current price move a recent operating benchmark, although the market capitalization remains far smaller than those of established Medicare Advantage insurers.

Price position in dollars

The primary Nasdaq quote stood at USD 4.73 at 2:53 p.m. ET on October 20, 2026, with a market capitalization of USD 2.5 billion and a price-to-earnings ratio of minus 113.58. The 52-week range was USD 1.58 to USD 5.59, leaving the quote 15.38 percent below its high.

For a direct industry comparison, UnitedHealth Group traded at USD 419.91, up 3.20 percent, with a price-to-earnings ratio of 23.96 and a market capitalization of USD 376.9 billion. Humana traded at USD 427.55, up 3.03 percent, with a price-to-earnings ratio of 40.54 and a market capitalization of USD 51.3 billion.

What does November 4 mean?

Clover Health's next scheduled financial event is its third-quarter earnings release on November 4, 2026, after the market closes, followed by a conference call at 5:00 p.m. ET. The date was announced by Clover Health on October 7, 2026.

A separate filing-related transaction involved Karen Soares selling 14,673 shares at an average USD 4.68 on October 15, 2026. MarketBeat said the sale followed a pre-arranged Rule 10b5-1 plan for tax withholding.

After-hours price stays elevated

The euro quotation is 15.38 percent below the Nasdaq 52-week high when measured in the primary currency, while the current market capitalization is USD 2.5 billion. The next earnings date gives investors a defined point for comparing enrollment, revenue and profitability against the second-quarter figures.

The further course of trading is shown by the continuously updated real-time quote of Clover Health stock.